Food noise on a GLP-1: what it is and what happens after stopping

Reviewed 21 sourcesPublished by PepVault

Food noise on a GLP-1: what the term means, how it is measured, what semaglutide and tirzepatide trials and users report, and what is known after stopping.

A woman in a sage tank top eating a salmon salad at a bright table
Last reviewed
Sources
21
Questions
8
Compounds
2

The short answer

Food noise is the name people gave to constant, unwanted thoughts about food. No trial has measured it under that name yet, but semaglutide and tirzepatide trials show less hunger, fewer cravings and better control of eating than placebo, and users report it going quiet. After stopping, appetite tends to return and most lost weight comes back within a year; plan any stop with your prescriber.

Every number checked at its primary source · · 21 sources · How we research

Evidence: Randomised placebo-controlled trials in people on appetite, cravings and weight (semaglutide and tirzepatide), the FDA labels for Wegovy and Zepbound, surveys and interviews of users, one single-person brain recording, and rodent studies for the brain pathways; no trial has yet measured food noise by name, and appetite after stopping comes from interviews and one small uncontrolled study.

A woman in a sage tank top eating a salmon salad at a bright table

What is food noise?

Food noise is a word that came from patients, not from a lab. As semaglutide spread, people taking it and their clinicians described a drop in what had come to be called food noise: less rumination and less preoccupation with food1. Researchers have since tried to pin it down. One group defines it as persistent, intrusive thoughts about food that disrupt daily life and make healthy habits harder2. Another adds that the thoughts feel unwanted or distressing, and that their intensity and intrusiveness set them apart from ordinary thinking about what to have for dinner3.

The first group to review it put food noise at the far end of food cue reactivity, the body's and mind's response to the sight, smell or thought of food: a heightened or persistent version of that response, often leading to intrusive food thoughts and eating that works against you1. It is not a diagnosis.

How many? In a nationally representative US survey of 1,000 adults in May 2026, 50.9% said they experience food noise at least occasionally and 18.0% often or always4. Frequent food noise was more common in women, younger adults and people reporting loss of control over eating4.

A smiling woman in a blue top leaning on her kitchen counter with her phone and a notebook

PepVault for iPhone

Keep your protocol in PepVault

Food in the PepVault app has a food noise row: tap Quiet, Normal or Loud once a day, and it draws your last 14 days with a tick under each day you logged a shot. The doctor's report shows the average as appetite, from 1 (quiet) to 5 (loud).

Download on the App Store

7 days free on the yearly plan for new subscribers.

How do researchers measure food noise?

Until 2025 there was no validated questionnaire, so the trials on GLP-1 drugs measured nearby things instead: hunger, fullness, cravings and how much people ate when given as much food as they wanted. Three tools matter for reading the evidence:

ToolWhat it asksWhere it has been used
Food Noise Questionnaire (FNQ), 2025Five statements such as "I spend too much time thinking about food", each scored 0 to 4, for a total of 0 to 20. Tested in 396 adults; scores held steady over a week (r = 0.79)2The INFORM survey of semaglutide users13
RAID-FN Inventory, 2025A second food noise questionnaire built on the formal definition above3Its developers' own studies3
Control of Eating Questionnaire (CoEQ)19 questions on hunger, fullness, cravings and how well you can resist them; Blundell 2017 used a 16-question short form1012The semaglutide appetite trials and STEP 5101112

The FNQ's developers include employees of WW International, the company behind WeightWatchers2. The CoEQ's craving-control scores are the closest thing the drug trials have to a food noise measure.

Why does a GLP-1 quiet food noise?

GLP-1 is a hormone the gut releases after a meal, and it is one of the body's own regulators of appetite and of how much is eaten5. Semaglutide copies it; tirzepatide acts on the GLP-1 receptor and on a second one, GIP56. Both labels state that these receptors sit in brain areas that regulate appetite, and that the drop in calorie intake is likely mediated by appetite56.

In people, GLP-1 receptors have been found on neurons in the hypothalamus (the brain's appetite center), the brainstem and part of the cortex, in tissue from 22 human brains7. In rats and mice, semaglutide reached the brainstem and hypothalamus and switched on neurons in 10 brain areas, including circuits that end a meal and circuits tied to reward8. These are animal results; the human evidence comes from brain scans.

Those scans point at the reward side, the part of the brain that makes food feel urgent. In a randomized trial of 114 adults, three weeks of tirzepatide lowered brain activity when people looked at photos of high-fat, high-sugar food, in areas including the orbitofrontal cortex, which weighs how rewarding food is, and lowered their self-reported cravings and reactivity to food around them, compared with placebo9. In 18 people with type 2 diabetes, 17 days of liraglutide, an older GLP-1 drug, dimmed the brain's response to pictures of highly desirable food7.

What did the trials find on hunger and cravings?

Every trial below was randomized, double-blind and placebo-controlled, in people with overweight or obesity. Each measured appetite directly, not only weight.

TrialWho and how longWhat changed against placebo
Blundell 2017, semaglutide30 adults with obesity, 12 weeks at up to 1.0 mg, crossover24% less food eaten across a day of all-you-can-eat meals; less hunger and fewer cravings; better control of eating; less preference for high-fat food10
Friedrichsen 2021, semaglutide72 adults with obesity, 20 weeks35% less eaten at an all-you-can-eat lunch; less hunger, more fullness; fewer and weaker cravings and better control of eating on the CoEQ11
STEP 5, semaglutide174 adults in the CoEQ subgroup, 2 yearsBetter craving control and fewer savoury cravings at weeks 20, 52 and 104; hunger and fullness differed only at week 2012
Martin 2025, tirzepatide114 adults, 6 weeksAbout 525 kcal less eaten at an all-you-can-eat lunch at week 3; less appetite, fewer cravings, less pull from food around them9
Four trials as bars on one week axis: Blundell 2017, 12 weeks, 24% less eaten; Friedrichsen 2021, 20 weeks, 35% less eaten; STEP 5, 2 years, craving control held to week 104; Martin 2025, 6 weeks, about 525 kcal less at lunch
Each bar is a placebo-controlled trial; only STEP 5 followed cravings for two years.

The pattern is consistent: the drugs turn down cravings and the urge to keep eating, not just stomach hunger. In STEP 5, the more a person's cravings improved, the more weight they had lost by week 10412.

What do people on a GLP-1 report?

These are reports, not trials. In the INFORM survey, 550 US adults on semaglutide for weight rated their food noise before starting, from memory, and now: the median FNQ score fell from 13 to 6 out of 20, and agreement with food noise statements fell from 47-63% to 15-20%13. The survey was run for Novo Nordisk, semaglutide's maker, and relied on recall13.

In 30 video interviews led by Stanford researchers, the first theme they listed was less food noise, psychological hunger or appetite, along with the view that the drug helps lifestyle change rather than replacing it14. In 31 interviews with people on obesity medications, those early in their weight loss described reduced food noise, early fullness and smaller portions; smaller portions lasted into the stable phase15.

Commonly reported: the background chatter about the next meal or snack fading within days to weeks of starting, with meals ending sooner and portions shrinking without effort. Some people describe it as the first time in years they did not think about food between meals.

Can food noise come back while you are still taking it?

It can change over time. In STEP 5, semaglutide's effect on hunger and fullness ratings showed against placebo only at week 20, while the effect on craving control held through two years12. In the interviews of 31 people, some in the stable phase described a sense that the drug was working less, and some considered switching15.

One rare case shows it inside the brain. A woman with type 2 diabetes and severe loss-of-control eating had electrodes placed in the nucleus accumbens, a reward hub, as part of a trial16. On tirzepatide, episodes of severe food preoccupation became rare in months two to four after surgery; in months five to seven it broke through again despite the maximum dose, and a low-frequency brain signal rose before it did16. That is one person, so it shows what can happen, not how often.

What happens to food noise after stopping a GLP-1?

No study has measured food noise by name after stopping (our PubMed search, November 20, 2026), but two have asked about appetite. In exit interviews from SURMOUNT-4, 36 of the 86 people had been switched to placebo without knowing it; of the 28 who talked about appetite in that phase, 24 said it got worse, such as wanting more to eat and willpower no longer coming easily20. In 28 women who stopped semaglutide after 36 weeks, 78.5% reported their appetite rebounding within 12 weeks21. The interviews were run for Eli Lilly, tirzepatide's maker, and the second study had no placebo group, so both show the direction, not the size.

Weeks after the last semaglutide shot: the drug leaves the blood over about 5 to 7 weeks; weight was tracked for a year, with two-thirds of the loss regained; the food noise lane is empty, never measured
Look at the empty lane: weight was tracked after stopping, appetite was not.

Weight is better measured. A year after semaglutide and the lifestyle program ended in the STEP 1 extension, people had regained two-thirds of the weight they had lost17. In SURMOUNT-4, people switched from tirzepatide to placebo gained 14.0% in weight over the next year, while those who stayed on it lost another 5.5%18.

The drug leaves slowly. Semaglutide has a half-life of about a week and stays in the blood for about 5 to 7 weeks after the last injection; tirzepatide's half-life is about 5 days56. So appetite would return over weeks, not days, though no placebo-controlled trial has tracked it after the last dose.

In the 2026 US survey, the 53 people who had stopped a GLP-1 within the past year reported frequent food noise more often than people who never used one (26.8% against 16.3%), and so did current users4. The authors think this most likely reflects who starts the drugs, people with obesity or insulin resistance, which go with stronger reactions to food cues, rather than an effect of the drugs4. The often repeated claim that food noise returns louder than before has no study behind it yet. The guide Stopping a GLP-1: what happens to your weight covers the regain in full.

How can you track your own food noise?

A daily rating turns a feeling into a record you and your prescriber can read, during treatment, around a dose change and after any stop.

  1. Pick one time each day, such as the evening, and rate the day's food noise as quiet, normal or loud.
  2. Mark the days you take your injection, so you can see how the noise runs across the week.
  3. Start a few days before a planned change (a new dose, a switch or a stop), so you have a baseline to compare against.
  4. Once a week, answer the five statements of the Food Noise Questionnaire if you want a 0-20 score that matches the research2.
  5. Bring the record to your next appointment, along with your weight.
An illustration of 14 days of food noise logged as quiet, normal or loud dots, with empty rings for days not logged and a tick under each weekly shot day
Read the dots against the ticks: the pattern across your week is the record your prescriber can use.

Food in the PepVault app has a food noise row: tap Quiet, Normal or Loud once a day, and it draws your last 14 days with a tick under each day you logged a shot. The doctor's report shows the average as appetite, from 1 (quiet) to 5 (loud). Track your food in PepVault

When to get help If thoughts about food feel out of your control, or you notice binge eating or making up for eating by vomiting, laxatives or fasting, tell your prescriber; an eating-disorder service can help too19.

Track it in the app

Sources

  1. Hayashi D et al. What is food noise? A conceptual model of food cue reactivity. Nutrients. 2023. PubMed 38004203
  2. Diktas HE et al. Development and validation of the Food Noise Questionnaire. Obesity (Silver Spring). 2025. PubMed 39828656
  3. Dhurandhar EJ et al. Food noise: definition, measurement, and future research directions. Nutr Diabetes. 2025. PubMed 40628707
  4. Hayashi D, Masterson TD. Prevalence and correlates of perceived food noise among U.S. adults in a nationally representative sample. Obes Sci Pract. 2026. PubMed 42801078
  5. Novo Nordisk. WEGOVY (semaglutide) injection and tablets, prescribing information. DailyMed, revised June 2026. dailymed.nlm.nih.gov
  6. Eli Lilly and Company. ZEPBOUND (tirzepatide) injection, prescribing information. DailyMed, revised August 2026. dailymed.nlm.nih.gov
  7. Farr OM et al. GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes. Diabetologia. 2016. PubMed 26831302
  8. Gabery S et al. Semaglutide lowers body weight in rodents via distributed neural pathways. JCI Insight. 2020. PubMed 32213703
  9. Martin CK et al. Tirzepatide on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial. Nat Med. 2025. PubMed 40555748
  10. Blundell J et al. Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes Obes Metab. 2017. PubMed 28266779
  11. Friedrichsen M et al. The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity. Diabetes Obes Metab. 2021. PubMed 33269530
  12. Wharton S et al. Two-year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5. Obesity (Silver Spring). 2023. PubMed 36655300
  13. Arnaut T et al. Retrospective assessment of food noise changes after initiation of injectable semaglutide for weight management in the USA: the INFORM survey. Adv Ther. 2026. PubMed 42217114
  14. de Vere Hunt I et al. Patient experiences with GLP-1 receptor agonists. JAMA Netw Open. 2026. PubMed 42247231
  15. Chong MC et al. Changes in eating behaviour during treatment with obesity medications. Clin Obes. 2026. PubMed 41420306
  16. Choi W et al. Brain activity associated with breakthrough food preoccupation in an individual on tirzepatide. Nat Med. 2025. PubMed 41249493
  17. Wilding JPH et al.; STEP 1 Study Group. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022. PubMed 35441470
  18. Aronne LJ et al.; SURMOUNT-4 Investigators. Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial. JAMA. 2024. PubMed 38078870
  19. Allison KC et al. Disordered eating attitudes and behaviors in individuals with BMI > 27 kg/m2 treated by semaglutide: a 60-week randomized placebo-controlled trial. Int J Eat Disord. 2026. PubMed 43035836
  20. Carmichael C et al. Patient experience of treatment with tirzepatide for weight management: exit interviews from SURMOUNT-4. Patient. 2025. PubMed 39987302
  21. Wang N et al. Post-semaglutide weight regain in females with obesity: associations with gut microbiota, bile acid metabolism, and central nervous system. Diabetes Obes Metab. 2026. PubMed 41705640

Newsletter · Weekly

The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

We’ll email you a link to confirm. Your address is used for the briefing only. Privacy

PepVault for iPhone

Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo